| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An overview of automated systems relevant in pharmaceutical salt screening
|
Kumar, Lokesh
|
|
2007
|
12 |
23-24 |
p. 1046-1053
8 p.
|
article
|
| 2 |
A Sorcerer's apprentice and The Rule of Five: from rule-of-thumb to commandment and beyond
|
Abad-Zapatero, Cele
|
|
2007
|
12 |
23-24 |
p. 995-997
3 p.
|
article
|
| 3 |
Combating cardiovascular disease with angiogenic therapy
|
Jacobs, Jack
|
|
2007
|
12 |
23-24 |
p. 1040-1045
6 p.
|
article
|
| 4 |
Contents
|
|
|
2007
|
12 |
23-24 |
p. i-
1 p.
|
article
|
| 5 |
Editorial Board
|
|
|
2007
|
12 |
23-24 |
p. iii-
1 p.
|
article
|
| 6 |
Integration of fragment screening and library design
|
Siegal, Gregg
|
|
2007
|
12 |
23-24 |
p. 1032-1039
8 p.
|
article
|
| 7 |
Multi-dimensional QSAR in drug discovery
|
Lill, Markus A.
|
|
2007
|
12 |
23-24 |
p. 1013-1017
5 p.
|
article
|
| 8 |
Novel compounds directed against the inhibition of protease cascades
|
Edwards, Paul
|
|
2007
|
12 |
23-24 |
p. 1083-1084
2 p.
|
article
|
| 9 |
One target–multiple indications: a call for an integrated common mechanisms strategy
|
Nielsch, Ulrich
|
|
2007
|
12 |
23-24 |
p. 1025-1031
7 p.
|
article
|
| 10 |
Pharmaceutical R&D in the spotlight: why is there still unmet medical need?
|
Schmid, Esther F.
|
|
2007
|
12 |
23-24 |
p. 998-1006
9 p.
|
article
|
| 11 |
Pharmacogenetics of EGFR and VEGF inhibition
|
Pander, Jan
|
|
2007
|
12 |
23-24 |
p. 1054-1060
7 p.
|
article
|
| 12 |
Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs
|
Vasconcelos, Teófilo
|
|
2007
|
12 |
23-24 |
p. 1068-1075
8 p.
|
article
|
| 13 |
Status of terpenes as skin penetration enhancers
|
Aqil, Mohammed
|
|
2007
|
12 |
23-24 |
p. 1061-1067
7 p.
|
article
|
| 14 |
The highly permeable blood–brain barrier: an evaluation of current opinions about brain uptake capacity
|
Fagerholm, Urban
|
|
2007
|
12 |
23-24 |
p. 1076-1082
7 p.
|
article
|
| 15 |
The role of mechanism-based pharmacokinetic–pharmacodynamic (PK–PD) modelling in translational research of biologics
|
Agoram, Balaji M.
|
|
2007
|
12 |
23-24 |
p. 1018-1024
7 p.
|
article
|
| 16 |
Unfinished business: target-based drug discovery
|
Brown, David
|
|
2007
|
12 |
23-24 |
p. 1007-1012
6 p.
|
article
|
Journal description